LILACS – Literatura Latinoamericana y del Caribe de Ciencias de la Salud

Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review

Figueiredo, Izabela Rodrigues; Rose, Sara Cardoso Paes; Freire, Nathália Bandeira; Patrocínio, Marina Stabile; Pierdoná, Natália; Bittencourt, Roberto José.

Rev. Assoc. Med. Bras. (1992, Impr.); 65 (2), 2019

SUMMARY Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are drugs that act by maintaining glycosuria. Recent studies have shown promising effects of these in the treatment of type 2 diabetes mellitus (DM2). However, there may be an increased risk of developing urinary tract infections (UTIs) in patien...

Compuestos de Bencidrilo/efectos adversos, Compuestos de Bencidrilo/uso terapéutico, Canagliflozina/efectos adversos, Canagliflozina/uso terapéutico, Diabetes Mellitus Tipo 2/complicaciones, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Glucósidos/efectos adversos, Glucósidos/uso terapéutico, Ensayos Clínicos Controlados Aleatorios como Asunto, Factores de Riesgo, Inhibidores del Cotransportador de Sodio-Glucosa 2/efectos adversos, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico, Infecciones Urinarias/etiología

Fulltext

Cetoacidosis diabética euglicémica asociada a inhibidor de cotransportador de sodio glucosa Tipo 2 en paciente con diabetes Mellitus Tipo 1

Diabetic ketoacidosis with mild hyperglycemia is a major complication of sodium-glucose cotransporter 2 inhibitors. Although its use is not approved for patients with type 1 diabetes mellitus, the drug is often prescribed with the hope of optimizing metabolic control. We report a 20 years old female with...